Beta Bionics (BBNX) Other Non-Current Liabilities (2023 - 2026)

Beta Bionics' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 289.5% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 289.5% YoY), while the FY2025 annual figure was $1.5 million, down 96.55% from the prior year.
• Other Non-Current Liabilities came in at $1.6 million for Q1 2026 at Beta Bionics, up from $1.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $44.9 million in Q4 2024 to a low of $400000.0 in Q1 2025.
• A 4-year average of $10.4 million and a median of $1.5 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities plunged 96.55% in 2025 and jumped 289.5% in 2026, its largest moves.
• Beta Bionics' Other Non-Current Liabilities stood at $22.3 million in 2023, then soared by 101.15% to $44.9 million in 2024, then plunged by 96.55% to $1.5 million in 2025, then climbed by 0.71% to $1.6 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.6 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison